NCT01519869View on ClinicalTrials.gov

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 11, 2019

Study Completion Date

October 11, 2019

Conditions
Primary Peritoneal CarcinomaOvarian CarcinomaFallopian Tube Carcinoma
Interventions
DRUG

neoadjuvant chemotherapy

platinum-based neoadjuvant chemotherapy followed by interval surgical debulking with platinum-based adjuvant chemotherapy

Trial Locations (1)

40536

University of Kentucky Markey Cancer Center, Lexington

All Listed Sponsors
lead

Rachel Miller

OTHER

NCT01519869 - Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma | Biotech Hunter | Biotech Hunter